$11.19 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter

Equities research analysts expect that HCA Healthcare Inc (NYSE:HCA) will post $11.19 billion in sales for the current quarter, Zacks Investment Research reports. Ten analysts have provided estimates for HCA Healthcare’s earnings. The lowest sales estimate is $10.94 billion and the highest is $11.36 billion. HCA Healthcare reported sales of $10.64 billion in the same quarter last year, which indicates a positive year over year growth rate of 5.2%. The firm is scheduled to announce its next quarterly earnings results on Tuesday, January 30th.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $11.19 billion for the current financial year, with estimates ranging from $43.01 billion to $43.41 billion. For the next fiscal year, analysts expect that the business will report sales of $45.38 billion per share, with estimates ranging from $44.51 billion to $46.32 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.45 earnings per share.

A number of analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of HCA Healthcare from a “strong sell” rating to a “hold” rating in a report on Tuesday, December 19th. Piper Jaffray Companies cut shares of HCA Healthcare from an “overweight” rating to a “neutral” rating and set a $81.00 target price for the company. in a report on Wednesday, January 3rd. Goldman Sachs Group assumed coverage on shares of HCA Healthcare in a report on Wednesday, January 3rd. They set a “neutral” rating for the company. Credit Suisse Group restated an “outperform” rating and set a $25.00 target price on shares of HCA Healthcare in a report on Tuesday, December 26th. Finally, Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price objective for the company. in a research note on Wednesday, December 20th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $88.70.

Shares of HCA Healthcare (NYSE HCA) traded down $0.01 during trading hours on Wednesday, reaching $88.79. 2,394,100 shares of the company were exchanged, compared to its average volume of 2,118,550. The company has a market capitalization of $32,120.00, a PE ratio of 12.63, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55. HCA Healthcare has a 1 year low of $71.18 and a 1 year high of $91.03. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.

In other HCA Healthcare news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction on Friday, December 15th. The shares were sold at an average price of $86.63, for a total transaction of $207,912.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. Insiders sold a total of 20,550 shares of company stock valued at $1,606,172 in the last ninety days. Company insiders own 2.90% of the company’s stock.

Several large investors have recently modified their holdings of the business. National Pension Service boosted its stake in shares of HCA Healthcare by 8.0% during the 4th quarter. National Pension Service now owns 310,755 shares of the company’s stock valued at $27,297,000 after buying an additional 22,924 shares during the period. Factory Mutual Insurance Co. acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at $7,027,000. AustralianSuper Pty Ltd acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at $24,410,000. Parametric Portfolio Associates LLC raised its holdings in shares of HCA Healthcare by 4.2% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,346,771 shares of the company’s stock valued at $107,190,000 after purchasing an additional 54,653 shares in the last quarter. Finally, IFM Investors Pty Ltd bought a new position in shares of HCA Healthcare during the 3rd quarter valued at $646,000. 75.35% of the stock is owned by institutional investors.

WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2018/01/17/11-19-billion-in-sales-expected-for-hca-healthcare-inc-hca-this-quarter.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit